Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 449

    Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing

    Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing

    supriya kashyap kashyap13 March 2017 11:21 AM IST
    Mumbai : Glenmark Pharmaceuticals Inc., USA, and Evestra, Inc. have completed a strategic development, license and commercialization agreement to...
    MedGenome launches liquid biopsy blood test Oncotrack for cancer detection in patients

    MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

    supriya kashyap kashyap13 March 2017 10:05 AM IST
    Mumbai : MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for...
    Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

    Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

    supriya kashyap kashyap12 March 2017 11:00 AM IST
    Washington : U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical...
    New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

    New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

    supriya kashyap kashyap12 March 2017 10:42 AM IST
    Holzkirchen : Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, presented data for its proposed biosimilar adalimumab...
    Dr Reddy’s Visakhapatnam Facility Gets 13 Observations From US Drug Regulator

    Dr Reddy’s Visakhapatnam Facility Gets 13 Observations From US Drug Regulator

    supriya kashyap kashyap12 March 2017 9:18 AM IST
    New Delhi : The U.S. drug regulator has made observations related to deviation from good manufacturing practices at Dr Reddy's Laboratories Ltd.’s...
    Lupin launches pain relief drug in US

    Lupin launches pain relief drug in US

    supriya kashyap kashyap11 March 2017 11:00 AM IST
    New Delhi : Drug firm Lupin announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.In a BSE filing, Lupin...
    Sanofi gears up for European generic drugs unit sale: sources

    Sanofi gears up for European generic drugs unit sale: sources

    supriya kashyap kashyap11 March 2017 10:08 AM IST
    London : French drug maker Sanofi (SASY.PA) is looking to hire advisers for the sale of its European generic drug business by the end of the month,...
    As biosimilars hit, EU pharma warns against blanket prescribing

    As biosimilars hit, EU pharma warns against blanket prescribing

    supriya kashyap kashyap11 March 2017 10:02 AM IST
    London : European drug makers, faced with increasing competition from cut-price copies of complex biotech drugs, cautioned doctors to take care when...
    USFDA clears Glenmarks investigational new drug application

    USFDA clears Glenmark's investigational new drug application

    supriya kashyap kashyap11 March 2017 9:18 AM IST
    New Delhi : Drug major Glenmark said the US health regulator has cleared its investigational new drug (IND) application to begin a phase two study of...
    Medical providers oppose Trump-backed health plan, Democrats take aim

    Medical providers oppose Trump-backed health plan, Democrats take aim

    supriya kashyap kashyap10 March 2017 12:49 PM IST
    Washington : The top U.S. doctors' organisation and several hospital groups came out strongly against a Republican plan backed by President Donald...
    USFDA issues warning letter to Megafine Pharma for Vapi plant

    USFDA issues warning letter to Megafine Pharma for Vapi plant

    supriya kashyap kashyap10 March 2017 12:47 PM IST
    New Delhi : The US health regulator has issued a warning letter to Mumbai-based Megafine Pharma for violations of good manufacturing norms at its Vapi...
    Zydus Cadila gets USFDA nod to market muscle relaxant in US

    Zydus Cadila gets USFDA nod to market muscle relaxant in US

    supriya kashyap kashyap10 March 2017 12:47 PM IST
    New Delhi : Drug firm Zydus Cadila has received approval from the USFDA to market tizanidine hydrochloride capsules, a muscle relaxant, in the...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok